Talks from high profile academic and clinical experts; senior government and industry representatives; and a patient representative will highlight how the UK is leading the way in pharmacogenetics and stratified medicine. This event provides a great opportunity to meet with colleagues from across all sectors involved in delivering personalised medicine to patients.
3rd International Transporter Consortium Workshop at ASCPT | March 13-14 2017 | Membrane Transporters in Drug Development
The International Transporter Consortium (ITC) will host its 3rd workshop focusing on new research in membrane transporters, particularly as they relate to drug development. This workshop will take place immediately before the ASCPT 2017 Annual Meeting, March 13-14, 2017, at the Omni Shoreham Hotel in Washington, DC.
The 3rd Workshop on Membrane Transporters in Drug Development is a two-day workshop, with speakers who are prominent transporter biologists from universities, regulatory agencies and pharmaceutical companies. The workshop will cover a range of topics in transporter biology, including the endogenous function of transporters, emerging transporters of importance in drug development, modeling of transporters, genomics and biomarker probes of transporters, as well as regulatory issues in transporter-mediated drug-drug interactions. Case studies representing perspectives of regulatory agencies (e.g., FDA and EMA) will be presented along with a panel discussion involving experts in the field to address questions from the attendees. Finally, there will be breakout groups of interested scientists who will focus on writing whitepapers, review articles and commentary to be published in a special issue of Clinical Pharmacology & Therapeutics.
Please visit the link for more information about the meeting agenda and registration (Don’t miss the huge discount for trainee/student member!).
This one-day symposium is organized by the Clinical Pharmacogenetics Implementation Consortium (CPIC ® ) as part of the Pharmacogenomics Research Network (PGRN) Symposium. Talks by world-class speakers from high profile academic, hospital and health service organizations will highlight how the USA and other countries are leading the way in strategizing the implementation of pharmacogenetics. This event will provide a great opportunity to meet with speakers from all sectors involved in pharmacogenetic implementation who will share their strategies and perspectives and provide tough examples for implementation. Further details and the registration link will soon be available here.
Location: Washington Marriott Wardman Park, Washington, DC, USA
Three main sessions and two panel discussions (see full agenda here):
Session I: Strategies for Implementing Pharmacogenetics
Session II: Tougher Cases for Implementation
Session III: Global Perspectives for Pharmacogenetics Implementation
The Expanding Universe of Pharmacogenomics
Sponsored by the Pharmacogenomics Research Network (PGRN)
Monday, October 17, 2016
The Pharmacogenomics Research Network (PGRN) is bringing together scientists who study the interactions between genomes and drug responses. This symposium, organized by the PGRN and open to all ASHG attendees and others, explores current topics in pharmacogenomics with sessions on innovative approaches for identifying genes that influence drug response, the role of pharmacogenomics in drug discovery, technologies used in pharmacogenomic studies, and the evolution of pharmacogenes.
In addition, there will be an interactive panel discussion with diverse stakeholders on issues affecting the clinical implementation of pharmacogenomic testing. This symposium will enable scientists from multiple disciplines to learn about work at the frontier of pharmacogenomics and identify new opportunities for advancing research in basic and translational pharmacogenomics.
A symposium organized by the Pharmacogenomics Research Network (PGRN)
The field of pharmacogenomics has received considerable attention recently, since President Obama announced the Precision Medicine Initiative earlier this year. Complementing this effort, NIGMS launched a new version of the Pharmacogenomics Research Network (PGRN), which plans to become a focus for pharmacogenomics research in the U.S. and internationally, bringing together scientists and clinicians in diverse fields and across multiple sectors, including clinical pharmacologists in academia, industry and at the FDA.